https://www.taxtmi.com/news?id=55987 ANVISA has granted commercial approval for Concept Medical's MagicTouch Sirolimus Coated Balloon for coronary artery disease, authorizing its sale in Brazil as the first sirolimus coated balloon for coronary use and enabling a metal free drug delivery alternative to drug eluting stents backed by the company's clinical trial evidence and ongoing regulatory filings for related device portfolios. en-us Wed, 17 Sep 2025 18:01:03 +0530 Wed, 17 Sep 2025 18:01:03 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=55987 ANVISA has granted commercial approval for Concept Medical's MagicTouch Sirolimus Coated Balloon for coronary artery disease, authorizing its sale in Brazil as the first sirolimus coated balloon for coronary use and enabling a metal free drug delivery alternative to drug eluting stents backed by the company's clinical trial evidence and ongoing regulatory filings for related device portfolios. News - Wed, 17 Sep 2025 18:01:03 +0530 https://www.taxtmi.com/news?id=55987